Showing results (111-120 of 344) with videos related to
Sort By:
Pageof 35
Japanese Journal of Clinical Oncology|May 25, 2024
Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3Shinsuke Iida, Satoshi Ito, Hisayuki Yokoyama, et al.International Journal of Clinical Oncology|October 2, 2021
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myelomaShinsuke Iida, Tohru Izumi, Takuya Komeno, et al.Journal of Alzheimer'S Disease : JAD|November 6, 2019
Flotillin is a Novel Diagnostic Blood Marker of Alzheimer's DiseaseMohammad Abdullah, Noriyuki Kimura, Hiroyasu Akatsu, et al.International Journal of Hematology|May 9, 2025
Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MMShinsuke Iida, Kazutaka Sunami, Shigeki Ito, et al.Annals of Hematology|April 21, 2025
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trialsMeletios Dimopoulos, Kazutaka Sunami, Xavier Leleu, et al.Human Pathology|March 10, 2012
Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specifiedSeiji Yamada, Fumihiko Sato, Hongjing Xia, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[A case of T-cell lymphoblastic lymphoma with multiple patchy shadows in both lung fields]Makoto Nakao, Tetsuya Oguri, Tatsuya Yoshida, et al.International Journal of Hematology|May 13, 2022
MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantationShinsuke Iida, Tadao Ishida, Toshihiro Miyamoto, et al.International Journal of Hematology|March 27, 2021
Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancerYoshiaki Marumo, Shigeru Kusumoto, Ayako Masaki, et al.Leukemia|July 30, 2022
Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemiaJolynn Zu Lin Ong, Rui Yokomori, Regina Wan Ju Wong, et al.Pageof 35